CHS INC (CHSCL) — Institutional Holders, Q2 2026
3 institutional investment managers reported a CHSCL position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $944.8K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
CHSCL in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Vermillion Wealth ManagementNew · +1,632 sh+$40.3K
Biggest sellers
- Hurley CapitalSold out · -800 sh-$19.7K
CHSCL 13F holders ranked 1–3 of 3
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | GRACE & WHITE#1 · 24,229 sh | 24,229 | $584.9K | — | 0.0% |
| 2 | TrueNorth#2 · 12,922 sh | 12,922 | $318.8K | 0.02% | 0.0% |
| 3 | Vermillion Wealth Management#3 · 1,632 sh | 1,632 | $41.1K | — | New |
Funds that sold out of CHSCL in Q2 2026 (1)
Held CHSCL at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Hurley Capital800 sh | 800 | $19.4K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.